Search the webpage

Created by Leona Damalakienė on  October 7, 2019  in category: News

Optical Coherence Tomography Angiography (OCT-A) is a novel non-invasive imaging technique to generate high resolution images of the retinal and choroidal microvasculature. By using motion contrast imaging, OCT-A can generate angiographic images without the need for intravenous dye injection.

At Experimentica, we are now implementing the use of OCT-A to quantify disease-associated changes in the microvasculature. Leveraging our ongoing efforts in artificial intelligence (AI) and machine learning, we anticipate that rodent OCT-A images will further improve the translatability from preclinical disease models in the very near future.

 

 

The OCT-A scans shown here were captured using the Spectralis® OCT-A module (Heidelberg Engineering, Germany). The animation shows the 3D rendering of a single scan from a naïve rat with representative still images obtained from the superficial vascular complex and the deep capillary plexus.   

 

Contact for media enquiries:

Dr. Leona Damalakiene
R&D Director
Experimentica Ltd.
Phone: +370 (686) 14 280
Email: leona@experimentica.com

LATEST NEWS

Experimentica Ltd. appoints new Director of Business Development

News
Kuopio, Finland, 27th January 2019: Experimentica Ltd., a global ophthalmic contract research organization (CRO) today announced the appointment of Guillaume ... Read More

Professional Development Programme at Experimentica in 2020

News
We are delighted to announce that professional development of our talented employees in 2020 will be co-funded by the European ... Read More

Meet us at SMi’s Ophthalmic Drugs Conference 2019 in London, UK, 2019

News
We are pleased to be a part of the 3rd Annual Ophthalmic Drugs Conference and Focus Day, taking place on ... Read More

Subscribe to Our Newsletter!

We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!